mir-34a blocks osteoporosis bone metastasis inhibiting osteoclastogenesis tgif2 
bone-resorbing osteoclasts significantly contribute osteoporosis bone metastases cancer1- micrornas play important roles physiology disease45 present tremendous therapeutic potential6 nonetheless micrornas regulate skeletal biology underexplored identify mir-34a novel critical suppressor osteoclastogenesis bone resorption bone metastatic niche mir-34a downregulated osteoclast differentiation osteoclastic mir-34a-overexpressing transgenic mice exhibit lower bone resorption higher bone mass conversely mir-34a knockout heterozygous mice exhibit elevated bone resorption reduced bone mass consequently ovariectomy-induced osteoporosis well bone metastasis breast skin cancers diminished osteoclastic mir-34a transgenic mice can effectively attenuated mir-34a nanoparticle treatment mechanistically identify transforming growth factor-beta-induced factor tgif2 essential direct mir-34a target pro-osteoclastogenic tgif2 deletion reduces bone resorption abolishes mir-34a regulation together using mouse genetic pharmacological disease models reveal mir-34a key osteoclast suppressor potential therapeutic strategy confer skeletal protection ameliorate bone metastasis cancers 
